Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Nature Communications
|
September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
Kevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2019
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway
Vishal Kothari, Jonathan F Goodwin, Shuang G Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate Cancer
William S Chen, Winston A Haynes, Rebecca Waitz, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cell Reports. Medicine
|
October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Nature Communications
|
September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
Kevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Cancer Research
|
June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2019
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway
Vishal Kothari, Jonathan F Goodwin, Shuang G Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate Cancer
William S Chen, Winston A Haynes, Rebecca Waitz, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cell Reports. Medicine
|
October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Cancer
|
December 9, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Vadim S Koshkin, Nicholas Henderson, Marihella James, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics
|
November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Haolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Page
of 9